CLINICAL REPORT A 32-month-old girl presented with a history of increased sweating mainly at night-time, reddening of the skin of hands and forearms, epigastric pain and weight loss of about 7% following a febrile illness 2 months prior to admission. On physical examination, she had erythema of both hands and forearms with cold, moist skin and was otherwise unremarkable. In particular, there were no café au lait macules, freckling, cutaneous neurofibromas, or Lisch nodules on eye examination. Her growth parameters were; length 98 cm (97th centile), weight 13.5 kg (50th centile), and OFC 50.2 cm (75th centile). Her blood pressure was elevated to 167/108 mm Hg (95th centile for 3 years: 110/69 mm Hg [National High Blood Pressure Education Program Working Group, 2004]). Initial laboratory findings were non-specific; virus-serology showed recent HHV6 infection. Chest X-ray, electrocardiogram and echocardiography were normal. Abdominal ultrasound identified a mass in the region of the right adrenal gland, which showed inhomogeneous gadolinium-uptake on magnetic resonance imaging (MRI). The presumed diagnosis of neuroblastoma was supported by a marked elevation of urinary vanillylmandelic acid, whereas urinary homovanillic acid and dopamine were within the normal range. However, I-123-metaiodobenzylguanidine (MIBG) scanning and F18-FDG-PET-CT did not show tracer-uptake by the tumor. Serial blood pressure measurements showed sustained arterial hypertension that was refractory to conventional antihypertensive treatment with nifedipine. Pheochromocytoma was confirmed by a marked elevation of serum-chromogranin A (855.1 ng/ml; normal range [NR] 0–100) and elevated plasma catecholamines: normetanephrine (4,781 pg/ml; NR: 0–200), noradrenaline (15,802 pg/ml; NR: 0–600), adrenaline (400 pg/ml; NR: 1–100), and dopamine (195 pg/ml; NR: 1–100). Metanephrine was within the normal range. Following pretreatment with phenoxybenzamine, partial right adrenalectomy was performed. Histopathology confirmed the diagnosis of pheochromocytoma with marked areas of necrosis (Fig. 1). One week after surgery, plasma and urinary catecholamines/metanephrins had returned to normal. Genetic workup identified a heterozygous mutation c.491A>G (Q164R) (Fig. 2) in exon 3 of the VHL gene. Due to the very young age of the patient we excluded additional mutations in exons 5, 8, 9, 10, 11, 13, 14, 15, and 16 of the RET-protooncogene and in the exons, at the exon–intron-borders and in the 5′ non-translated regions of the SDHB-, SDHD-, and SDHC genes by molecular genetic analysis. Screening of the patient for other manifestations of VHL (retinal and CNS hemangioblastomas, endolymphatic sac tumors, renal, and pancreatic cysts) by MRI imaging of abdomen, head and spine as well as fundus examination did not identify other manifestations of VHL. Upon follow-up, the child gained 4 kg of weight within 4 months and she is normotensive with normal urinary and plasma metanephrins.
PatientID: 1 (case)
KindredID: 1
Case: F, 5Y5M, Ethnicity Unknown
DiseaseAssertion: pheochromocytoma
FamilyInfo: Extended analyses of her relatives (parents, a sibling, and, subsequently, in the paternal grandparents) showed that the mutation occurred de novo in the patient’s father who was subsequently diagnosed with bilateral pheochromocytomas and a retinal angioma.
CasePresentingHPOs: HP:0006748 (adrenal pheochromocytoma)
CaseHPOFreeText: At 2.75Y, the young girl presented with pheochromocytoma, after presenting with a history of increased sweating mainly at night-time, reddening of the skin of hands and forearms, epigastric pain and weight loss. Abdominal ultrasound identified a mass in the region of the right adrenal gland, which showed inhomogeneous gadolinium-uptake on magnetic resonance imaging
CaseNotHPOs: HP:0009711; HP:0010797; HP:0030393; HP:0000107; HP:0001737 (retinal capillary hemangioma, hemangioblastomas. endolymphatic sac tumor, renal cyst, pancreatic cysts)
CaseNotHPOFreeText: retinal and CNS hemangioblastomas, endolymphatic sac tumors, renal, and pancreatic cysts) by MRI imaging of abdomen, head and spine as well as fundus examination did not identify other manifestations of VHL. Additionally, there were no caf?e au lait macules, freckling, cutaneous neurofibromas, or Lisch nodules on eye examination.
CasePreviousTesting: RET, SDHB, SDHC, SDHD
PreviouslyPublished: N/A
SupplementalData: N/A
Variant: p.Q164R (c.491A>G)
LegacyVariant: N/A
CaseProblemVariantFreeText: N/A
ClinVarID: 2238 https://www.ncbi.nlm.nih.gov/clinvar/variation/2238/
CAID: N/A
gnomAD: N/A
VariantEvidence: N/A
MutationType: missense_variant;transition
CivicName: Q164R (c.491A>G)
MultipleGeneVariants: N/A